Jane Street Group, LLC Sorrento Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $204,448 - $505,596	276,282 Added 60.76%	731,024 $650,000
Q3 2022 Nov 14, 2022	SELL	$1.51 - $2.88 $540,173 - $1.03 Million	-357,731 Reduced 44.03%	454,742 $714,000
Q3 2022 Nov 14, 2022	SELL	$1.51 - $2.88 $540,173 - $1.03 Million	-357,731 Reduced 44.03%	454,742 $714,000
Q2 2022 Aug 16, 2022	BUY	$1.24 - $2.33 $802,359 - $1.51 Million	647,064 Added 391.19%	812,473 $1.63 Million
Q1 2022 May 17, 2022	BUY	$2.0 - $4.9 $97,882 - $239,810	48,941 Added 42.02%	165,409 $386,000
Q4 2021 Feb 15, 2022	BUY	$4.65 - $7.23 $293,782 - $456,784	63,179 Added 118.56%	116,468 $542,000
Q3 2021 Nov 16, 2021	SELL	$7.41 - $10.99 $33,070 - $49,048	-4,463 Reduced 7.73%	53,289 $407,000
Q2 2021 Aug 16, 2021	SELL	$6.35 - $10.0 $983,291 - $1.55 Million	-154,849 Reduced 72.84%	57,752 $559,000
Q1 2021 May 18, 2021	SELL	$7.03 - $16.51 $6.14 Million - $14.4 Million	-873,878 Reduced 80.43%	212,601 $1.76 Million
Q4 2020 Feb 17, 2021	BUY	$5.76 - $11.95 $1.44 Million - $3 Million	250,679 Added 29.99%	1,086,479 $7.42 Million
Q3 2020 Nov 17, 2020	BUY	$6.17 - $18.82 $4.79 Million - $14.6 Million	775,735 Added 1291.49%	835,800 $9.32 Million
Q2 2020 Aug 17, 2020	BUY	$1.73 - $6.76 $11,352 - $44,359	6,562 Added 12.26%	60,065 $378,000
Q1 2020 May 15, 2020	BUY	$1.57 - $4.76 $36,389 - $110,327	23,178 Added 76.43%	53,503 $98,000
Q3 2019 Nov 14, 2019	BUY	$2.05 - $2.69 $37,392 - $49,065	18,240 Added 150.93%	30,325 $65,000
Q2 2019 Aug 15, 2019	BUY	$2.67 - $4.38 $32,266 - $52,932	12,085 New	12,085 $32,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account